In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation

The effects of eltrombopag, a thrombopoietin-receptor agonist, on platelet function in immune thrombocytopenia (ITP) are not fully characterized. This study used whole blood flow cytometry to examine platelet function in 20 patients receiving eltrombopag treatment at days 0, 7, and 28. Platelet surf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Psaila, Bethan, Bussel, James B., Linden, Matthew D., Babula, Bracken, Li, Youfu, Barnard, Marc R., Tate, Chinara, Mathur, Kanika, Frelinger, Andrew L., Michelson, Alan D.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Platelets and Thrombopoiesis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3350368/
https://ncbi.nlm.nih.gov/pubmed/22294727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-11-393900
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars